Research News and Research

RSS

Genes in Tasmanian Devil give new hope to children with cancer

Cancer researchers have generated a genetic blueprint of the Tasmanian Devil genome, revealing cancer-associated genes that may answer important questions about adult and childhood cancer.

30 Jun 2011

Modulating interaction between 'rotten eggs' gas and nitric oxide may treat heart failure

Research carried out by scientists from the Peninsula Medical School at the University of Exeter and the National University of Singapore has analysed the complex 'cross talk' between hydrogen sulphide and nitric oxide, both gasses that occur naturally in the body, and found that the interaction may offer potential strategies in the management of heart failure.

30 Jun 2011

Pregenen, Cellectis partner to develop meganucleases

Cellectis, the French genome engineering specialist, announced today the signing of a collaboration agreement with Pregenen, an American biotechnology start-up company dedicated to the creation of innovative tools for genome engineering.

30 Jun 2011

Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debate

The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocked in court. It makes deep cuts in state programs that will have unwelcome repercussions in years to come. And if the revenue projections prove to be as overly optimistic as they seem, there will be more damaging cuts to education, child care and health services. Nevertheless, it's a more earnest effort to clean up the state's budget mess than Sacramento has seen in a decade or more.

30 Jun 2011

Vaccines may be given in food in the near future

Soon children could be vaccinated with bacteria mixed in milk and people in the developing world given unprecedented access to immunisations under a scheme proposed by an Australian Nobel laureate, Barry Marshall.

29 Jun 2011

FDA looks at Avastin risks

The US Food and Drug Administration is holding a two-day hearing that pits the FDA's Center for Drug Evaluation and Research against Genentech, that manufactures breast cancer drug Avastin. A handful of breast cancer patients testified Tuesday that Avastin helped in treating their metastatic breast cancer but a review of studies conducted by the FDA's Center for Drug Evaluation and Research suggests the risks outweigh the benefits of Avastin for treating breast cancer, FDA officials said at the hearing.

29 Jun 2011

Gene overexpression linked with Alzheimer's disease and Down syndrome

Chronic stress has long been linked with neurodegeneration. Scientists at USC now think they may know why.

29 Jun 2011

Patients, scientists in different corners for cancer drug fight

The drug, Avastin, will be the subject of an unusual Food and Drug Administration hearing to revisit a panel vote last July that steered many doctors away from prescribing the drug for the treatment of breast cancer.

29 Jun 2011

Interest, uncertainty surround health exchanges, ACOs

In other news related to health law implementation, Sen. Jerry Moran, R-Kan., has co-sponsored legislation to allow states to opt out of the health law until legal challenges related to it are resolved.

29 Jun 2011

China Health first quarter gross revenues increase 52% to $6.759 million

China Health Labs & Diagnostics Ltd. is pleased to announce the financial results for the first quarter ended March 31, 2011.

29 Jun 2011

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that it has entered into a definitive distribution and supply agreement with Vertical Pharmaceuticals, Inc., a U.S.-based specialty pharmaceutical company, under which Cipher has granted Vertical the exclusive right to market, sell and distribute CIP-TRAMADOL ER in the United States.

29 Jun 2011

Newly revised and expanded editions of CRA's and CRC's guides released

CenterWatch, a leading publisher in the clinical trials industry, announced today the release of newly revised and expanded editions of two of its top-selling training resources—The CRA's Guide to Monitoring Clinical Trials, 3rd Edition, and The CRC's Guide to Coordinating Clinical Trials, 2nd Edition.

29 Jun 2011

LVAD therapy an 'attractive option' for heart failure patients 70 years of age or older

Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart failure.

29 Jun 2011

First Edition: June 29, 2011

In today's news, two senators offer a new plan for Medicare cuts -- which includes increasing the eligibility age -- but top Democrats lined up against it.

29 Jun 2011

RxMD and GlycoRegImmune enter drug development collaboration

RxMD, Inc., a privately-held, global therapeutics development company, today announced a collaboration agreement with GlycoRegImmune Inc. (GRI) to develop new treatments for inflammatory, autoimmune, and neurodegenerative conditions based on GRI's novel natural killer (NK) T cell targeted technologies.

29 Jun 2011

South African circumcision program moving forward with support from Zulu king

NPR's Morning Edition on Monday examined how a circumcision program in South Africa's Kwa-Zulu Natal, run by the Society for Family Health at the Boom Street Community Health Clinic, "is gaining momentum" because of a decree issued last year by King Goodwill Zwelithini kaBhekuzulu about the importance of circumcision in helping to reduce the risk of HIV infection.

29 Jun 2011

NPR examines maternal, child health in Mozambique

NPR's All Things Considered reports on efforts to improve maternal health in Mozambique. The piece, which is part of a summer series, looks at the challenges involved with getting pregnant women to hospitals and shortages of trained health worker (Block, 6/27).

29 Jun 2011

GenSpera and University of Copenhagen collaborate on 'Sustainable Production of Thapsigargin using Light'

GenSpera, Inc. has entered into a cooperation agreement with the University of Copenhagen, in Copenhagen, Denmark, to collaborate on the "SPOTLight" (Sustainable Production of Thapsigargin using Light) project.

29 Jun 2011

South Sudan should use military as force for development

Calestous Juma, an author and professor at Harvard Kennedy School, writes in an East African opinion piece that as South Sudan prepares for independence on July 9, it "is the time" for the country "to chart a new path by defining a new role for its military" by "shift[ing] its military budget to development objectives."

29 Jun 2011

PEP intervention increases breast cancer awareness

Educating women about breast cancer increases their knowledge about the disease should they develop a symptom - and could help increase survival from breast cancer, new research today shows.

29 Jun 2011